Michael McEwan

1.7k total citations
48 papers, 1.1k citations indexed

About

Michael McEwan is a scholar working on Physiology, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Michael McEwan has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Physiology, 22 papers in Molecular Biology and 14 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Michael McEwan's work include Smoking Behavior and Cessation (27 papers), Nicotinic Acetylcholine Receptors Study (15 papers) and Air Quality and Health Impacts (9 papers). Michael McEwan is often cited by papers focused on Smoking Behavior and Cessation (27 papers), Nicotinic Acetylcholine Receptors Study (15 papers) and Air Quality and Health Impacts (9 papers). Michael McEwan collaborates with scholars based in United Kingdom, United States and Germany. Michael McEwan's co-authors include Nathan Gale, George Hardie, Graham Errington, Evan O. Gregg, James J. Murphy, Oscar M. Camacho, Christopher Proctor, Gerhard Scherer, Alison Eldridge and Francis Cheung and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and BMC Public Health.

In The Last Decade

Michael McEwan

45 papers receiving 1.0k citations

Peers

Countries citing papers authored by Michael McEwan

Since Specialization

Citations

This map shows the geographic impact of Michael McEwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael McEwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael McEwan more than expected).

Fields of papers citing papers by Michael McEwan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael McEwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael McEwan. The network helps show where Michael McEwan may publish in the future.

Co-authorship network of co-authors of Michael McEwan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael McEwan. A scholar is included among the top collaborators of Michael McEwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael McEwan. Michael McEwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Randomized Crossover Clinical Study to Assess the Effect of Oral Nicotine Pouches Used for Different Durations on Plasma Nicotine Pharmacokinetics in Healthy Oral Pouch Consumers 2025 ·The Journal of Clinical Pharmacology ·David Azzopardi, Elaine Brown, (unknown), Stacy Fiebelkorn, Linsey E. Haswell, George Hardie, Michael McEwan	0
2	An adverse outcome pathway for cigarette smoke-mediated oxidative stress in plaque formation 2025 ·Frontiers in Toxicology ·Patrudu Makena, Linsey E. Haswell, Michael McEwan, Brian M. Keyser, David E. Smart, Robert Leverette, Kristen G. Jordan, Damien Breheny, (unknown)	0
3	Supporting active engagement of adults with intellectual disabilities in lifestyle modification interventions: a realist evidence synthesis of what works, for whom, in what context and why 2024 ·Journal of Intellectual Disability Research ·(unknown), (unknown), Nishant Jaiswal, Olívia Wu, Arlene M. McGarty, Craig Melville, Louisa Ells, Phillippa Lally, Michael McEwan, Leanne Harris, Evi Germeni	2
4	Lifestyle modification interventions for adults with intellectual disabilities: systematic review and meta‐analysis at intervention and component levels 2024 ·Journal of Intellectual Disability Research ·(unknown), (unknown), Nishant Jaiswal, Evi Germeni, Arlene M. McGarty, Louisa Ells, Phillippa Lally, Michael McEwan, Craig Melville, Leanne Harris, Olívia Wu	2
5	Exploring approaches to community music delivery by practitioners with and without additional support needs: A qualitative study 2022 ·International Journal of Community Music ·(unknown), Graeme Wilson, (unknown), Kirsty Brown, Michael McEwan, Raymond MacDonald	2
6	An abuse liability assessment of the glo tobacco heating product in comparison to combustible cigarettes and nicotine replacement therapy 2022 ·Scientific Reports ·George Hardie, Nathan Gale, Michael McEwan, (unknown), Luigi Ziviani, Christopher Proctor, James J. Murphy	10
7	A randomized controlled study in healthy participants to explore the exposure continuum when smokers switch to a tobacco heating product or an E-cigarette relative to cessation 2021 ·Toxicology Reports ·Michael McEwan, Nathan Gale, (unknown), Oscar M. Camacho, George Hardie, Christopher Proctor, James J. Murphy	25
8	Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: protocol for a mixed-methods systematic review 2021 ·Systematic Reviews ·(unknown), (unknown), Evi Germeni, Arlene M. McGarty, Louisa Ells, Phillippa Lally, Michael McEwan, Craig Melville, Leanne Harris, Olívia Wu	3
9	A randomised controlled single-centre open-label pharmacokinetic study to examine various approaches of nicotine delivery using electronic cigarettes 2020 ·Scientific Reports ·(unknown), Michael McEwan, Nathan Gale, Oscar M. Camacho, George Hardie, Christopher Proctor	20
10	Nicotine pharmacokinetics of electronic cigarettes: A review of the literature 2018 ·Regulatory Toxicology and Pharmacology ·Ian M. Fearon, Alison Eldridge, Nathan Gale, Michael McEwan, Mitchell F. Stiles, (unknown)	39
11	A randomised, controlled, two-Centre open-label study in healthy Japanese subjects to evaluate the effect on biomarkers of exposure of switching from a conventional cigarette to a tobacco heating product 2017 ·BMC Public Health ·Nathan Gale, Michael McEwan, Alison Eldridge, N. Sherwood, (unknown), (unknown), (unknown), (unknown), Stuart Hossack, Oscar M. Camacho, Graham Errington, John McAughey, James J. Murphy, Chuan Liu, Christopher Proctor, Ian M. Fearon	18
12	E-cigarette Nicotine Delivery: Data and Learnings from Pharmacokinetic Studies 2016 ·American Journal of Health Behavior ·Ian M. Fearon, Alison Eldridge, Nathan Gale, (unknown), Michael McEwan, Oscar M. Camacho, (unknown), Kevin McAdam, Christopher Proctor	24
13	Comparison of Mouth Level Exposure to ‘Tar’ and Nicotine in Smokers of Normal and Superslim King Size Cigarettes in Romania 2011 ·Beiträge zur Tabakforschung international ·(unknown), (unknown), Michael McEwan, John McAughey, Krishna Prasad	11
14	An inter-laboratory comparison of urinary 3-hydroxypropylmercapturic acid measurement demonstrates good reproducibility between laboratories 2011 ·BMC Research Notes ·Emmanuel Minet, Graham Errington, Gerhard Scherer, (unknown), Mehran Sharifi, Brian J. Bailey, Michael McEwan, Francis Cheung	5
15	A liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in urine of non-smokers and smokers 2010 ·Analytical and Bioanalytical Chemistry ·(unknown), (unknown), (unknown), Johannes Engl, Gerhard Scherer, Michael McEwan, Graham Errington, (unknown), Francis Cheung	60
16	Determination of tobacco-specificN-nitrosamines in urine of smokers and non-smokers 2009 ·Biomarkers ·Dominique Kavvadias, Gerhard Scherer, Francis Cheung, Graham Errington, (unknown), Michael McEwan	38
17	Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine 2009 ·Journal of Chromatography B ·Dominique Kavvadias, Gerhard Scherer, Michael Urban, Francis Cheung, Graham Errington, (unknown), Michael McEwan	55
18	Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers 2009 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Frazer Lowe, Evan O. Gregg, Michael McEwan	48
19	A study to estimate and correlate cigarette smoke exposure in smokers in Germany as determined by filter analysis and biomarkers of exposure 2009 ·Regulatory Toxicology and Pharmacology ·(unknown), Alison Eldridge, Derek C. Mariner, Michael McEwan, Graham Errington, Michael Dixon	69
20	Action of cysteaminylphenols on human melanoma cells in vivo and in vitro 1991 ·Melanoma Research ·Peter G. Parsons, (unknown), Michael McEwan, Hiromasa Takahashi, (unknown), Shosuke Ito	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact